This article was originally published on June 23, 2022 and has been updated in October 2023. Blue & Co. has performed many Emergency Department Leveling Reviews for hospitals. The two […]
Read More
In 2019 patient medical debt in the U.S. totaled at least $195 billion, according to an analysis by the Kaiser Family Foundation, a nonprofit organization focusing on national health issues. […]
Read More
In a previous blog post, we talked about how poor insurance verification and authorization processes can cause patients to either not come to therapy or to go to a competitor […]
Read More
It is that time of year again! The Center for Medicare and Medicaid Services (CMS) has issued the proposed rule that would update Medicare payment policies and rates for the […]
Read More
One of the most challenging conversations in any multi-physician practice or specialty-based hospital employed group is about how to create a fair distribution of on-call and/or inpatient hospital service coverage […]
Read More
“There may be no faster death of a great idea or business than a dysfunctional team”, said Daniel Newman from Principal Analyst of Futurum Research and the CEO of Broadsuite […]
Read More
Many outpatient therapy departments think of a no-show and cancellation reduction plan as a discharge plan. For example, if a patient does not show up a certain number of times, […]
Read More
Great news for 340B Hospitals affected by COVID-19. On March 15, 2022, President Biden signed into law the $1.5 trillion Consolidated Appropriations Acts, 2022. This bill allows Hospitals that have […]
Read More
The Two Midnight rule, adopted in October 2013 by the Centers for Medicare and Medicaid Services, states that more highly reimbursed inpatient payment is appropriate if care is expected to […]
Read More
Elective surgical practices have suffered significantly since the beginning of the COVID-19 pandemic. Patients seeking elective surgical treatment had their procedures postponed or canceled as hospital systems were striving to […]
Read More
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
By Joell Grisel, CPA, Director at Blue & Co. Financial technology keeps evolving at a pace that is hard for many not-for-profits to keep up with. At Blue & Co., […]
In early April 2026, a notice was sent from CMS to each MAC regarding the April 30th, 2026, release of the final FY 2027 wage index data PUFs. May 29th, […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
